Cancer stem cell populations in lymphoma in dogs and impact of cytotoxic chemotherapy

Veterinary and Comparative Oncology
G HartleySteven W Dow

Abstract

Cancer relapse following chemotherapy has been attributed in part to the presence of cancer stem cells (CSC), which drive tumour growth and metastasis and are highly resistant to the effects of cytotoxic chemotherapy. As a result, treatment with cytotoxic chemotherapy selects for drug-resistant CSC populations that eventually drive tumour recurrence. Little is known currently regarding the role of CSC in dogs with lymphoma, nor the impact of chemotherapy on CSC populations. Therefore, we prospectively quantitated CSC populations in dogs with B-cell (BCL) and T-cell lymphoma (TCL), using tumour aspirates and flow cytometric analysis with a panel of CSC markers. In addition, in vitro studies were carried out to determine the impact of chemotherapy resistance on the stem cell phenotype and stem cell properties of lymphoma cells. We found that the percentages of tumour cells expressing CSC markers were significantly increased in dogs with BCL, compared with B cells from normal lymph nodes. Similar findings were observed in dogs with TCL. In vitro studies revealed that lymphoma cells selected for resistance to CHOP chemotherapy had significantly upregulated expression of CSC markers, formed spheroids in culture more readily, and exp...Continue Reading

References

Jan 1, 1987·Cancer Immunology, Immunotherapy : CII·Z SteplewskiN Weintraub
Dec 1, 1996·British Journal of Cancer·M A IzquierdoR J Scheper
Nov 2, 2001·Nature·T ReyaI L Weissman
Nov 26, 2003·Mutation Research·Geir SlupphaugHans E Krokan
Apr 3, 2004·British Journal of Haematology·Francesco BuccisanoValter Gattei
Sep 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·C Hirschmann-JaxM K Brenner
Dec 14, 2005·Current Opinion in Genetics & Development·Thomas O'HareBrian J Druker
Dec 21, 2006·Cell Research·Feng LiYibin Kang
May 29, 2007·Leukemia Research·William C KisseberthThomas J Rosol
Jun 20, 2007·Proceedings of the National Academy of Sciences of the United States of America·Naoki HosenIrving L Weissman
Nov 22, 2007·Expert Opinion on Drug Metabolism & Toxicology·Michael Michael, Margaret M Doherty
Jan 17, 2008·Cell Cycle·Ulf R RappRalf Schreck
Feb 5, 2008·Cancer Cell·Zhen Fan YangSheung Tat Fan
Mar 19, 2008·Journal of Veterinary Internal Medicine·M J WilliamsP R Avery
May 1, 2008·Journal of the National Cancer Institute·Xiaoxian LiJenny C Chang
Jul 10, 2008·Expert Opinion on Drug Metabolism & Toxicology·Satori A MarchittiVasilis Vasiliou
Feb 4, 2009·Blood·Richard J JonesWilliam Matsui
May 8, 2009·Clinical & Experimental Metastasis·Jennifer L Dembinski, Stefan Krauss
Aug 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·Chad J CreightonJenny C Chang
Oct 7, 2009·Cell Cycle·Christophe GinestierEmmanuelle Charafe-Jauffret
Feb 18, 2010·Nature Biotechnology·Yoriko SaitoFumihiko Ishikawa
Sep 10, 2010·The New England Journal of Medicine·Ramin TehranchiSten Eirik W Jacobsen
Dec 24, 2010·Cancer Research·Mark P ChaoRavindra Majeti
May 24, 2011·Leukemia & Lymphoma·Hyun Joo JungNami McCarty
Sep 13, 2011·Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc·Liza E O'DonoghueDawn L Duval
Sep 22, 2011·Journal of Dental Research·S Krishnamurthy, J E Nör
Dec 14, 2011·Histochemistry and Cell Biology·Eizo NakagawaHan-Sung Jung
Mar 28, 2012·Proceedings of the National Academy of Sciences of the United States of America·Stephen B WillinghamIrving L Weissman

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.